Our leadership team brings together the unique talents of world-leading physicians and scientists. We have dedicated years of research to developing safe, non-invasive alternatives to traditional testing methods. We all share the same vision to empower patients and clinicians through a greater understanding of liver disease, and we aim to create a culture of patient-centric innovation throughout the organization.
Interim CEO
Dr Rexford Newbould
Chief Strategy Officer
Dr Keri Hildick
Co-founder
Professor Sir Michael Brady
Chief Technical Officer
Dr Matthew Robson
President Pharma Solutions
Marija Mavar
VP People Success
Mehru Asad
SVP Investor Relations
Amanda Chin
VP Operations